article thumbnail

The inner workings of environmental bacterium

Drug Target Review

A team led by Professor Dr Ralf Rabus, a microbiologist at the University of Oldenburg, in collaboration with his doctoral student Patrick Becker, has achieved profound insights into the inner workings of a prevalent environmental bacterium.

article thumbnail

How organoids can redefine pre-clinical research

Drug Target Review

She received her Doctor of Philosophy in Biochemistry & Molecular Biology at the Graduate University of Chinese Academy of Sciences, Beijing, China, and a Master of Medicine in Toxicology at The Academy of Military Medical Sciences, Beijing, China.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

My Attendance at the 2024 Boston Society Cell and Gene Therapy Conference

Alta Sciences

Our experts have over five years of experience with CRISPR gene-editing therapeutics in nonhuman primates (NHPs) and extensive expertise in bioanalysis for biodistribution studies, in addition to many molecular biology platforms , such as ligand binding assays (LBA), NAbs, TAbs, flow cytometry , and ELISpot.

article thumbnail

Precision Medicine – it’s not just for oncology anymore

The Pharma Data

In the past two decades we have learned so much in oncology about the molecular biology of cancer and that has led to better treatments for patients. By using these approaches, we hope to not only accelerate medicine development but also someday put these tools in the hands of patients and doctors to help guide treatment decisions.”.

article thumbnail

Women in Stem with Joanne Kanaan

Drug Target Review

When choosing my bachelor’s degree, the choice was between pursuing a career in biology or in computer science. Biology won that battle, and I pursued a bachelor’s and master’s degree in biochemistry and molecular biology.

article thumbnail

F. William Studier receives the 2024 Merkin Prize in ceremony at the Broad Institute for developing technology used to produce millions of doses of COVID-19 vaccines

Broad Institute

HPN develops and manages coordinated, patient-doctor centric, integrated health care systems that offer some of the strongest solutions for the future of health, care, and cost in the United States. He has a humble, self-effacing demeanor, and yet he is great at pushing people to make bold bets and to try to make the impossible possible."

Vaccine 64
article thumbnail

Mediating BRAF-mutant melanoma resistance

Drug Target Review

Dr Alani also directs a clinical program at Boston Medical Center focused on patients with melanoma and other high-risk skin cancers and has been recognized as a 2024 Boston Magazine and Castle Connolly Top Doctor. Dr Alani further developed her research interests as a research fellow at Memorial Sloan-Kettering Cancer Center.